Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kidney de Novo Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00154232
What this trial is testing

Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 46
Testing effectiveness (Phase 2)Study completedNCT00820911
What this trial is testing

Efficacy and Safety of AEB071 Versus Cyclosporine in de Novo Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 175
Testing effectiveness (Phase 2)Study completedNCT02970630
What this trial is testing

Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Study

Who this might be right for
Kidney Transplantation
Chiesi Farmaceutici S.p.A. 28
Testing effectiveness (Phase 2)Study completedNCT00617604
What this trial is testing

Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients

Who this might be right for
De Novo Kidney Transplantation
Astellas Pharma Inc 218
Large-scale testing (Phase 3)Study completedNCT01843348
What this trial is testing

12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients

Who this might be right for
Kidney TransplantationRenal Transplantation
Novartis Pharmaceuticals 612
Large-scale testing (Phase 3)Study completedNCT00369278
What this trial is testing

Intensified vs. Standard Dose Therapy With Mycophenolate Sodium Plus Cyclosporin Microemulsion and Corticosteroid Combination in Patients With de Novo Renal Transplant Patients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 128
Testing effectiveness (Phase 2)Study completedNCT00270634
What this trial is testing

Study of ISA247 (Voclosporin) in De Novo Renal Transplantation

Who this might be right for
Kidney Diseases
Aurinia Pharmaceuticals Inc. 334
Testing effectiveness (Phase 2)Study completedNCT00003408
What this trial is testing

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Cancer Treatment Centers of America 40
Large-scale testing (Phase 3)Study completedNCT01595984
What this trial is testing

Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME)

Who this might be right for
Kidney Failure
Centre Hospitalier Universitaire, Amiens 88
Post-approval studies (Phase 4)Study completedNCT00507793
What this trial is testing

Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving Sirolimus

Who this might be right for
Kidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 385
Post-approval studies (Phase 4)Study completedNCT00817687
What this trial is testing

The Impact of an Early Biopsy in Patients Treated With CellCept (Mycophenolate Mofetil) After Kidney Transplantation

Who this might be right for
Kidney Transplantation
Hoffmann-La Roche 66
Large-scale testing (Phase 3)Study completedNCT01305200
What this trial is testing

Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant

Who this might be right for
Childhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Chronic Myelogenous Leukemia+24 more
Children's Oncology Group 226
Large-scale testing (Phase 3)Study completedNCT00720265
What this trial is testing

Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation Patients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 135
Post-approval studies (Phase 4)UnknownNCT02154854
What this trial is testing

Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE)

Who this might be right for
De Novo Transplant Disease
University Hospital, Tours 104
Not applicableUnknownNCT01382355
What this trial is testing

Prospective Donor Specific Antibody (DSA) Monitoring Protocol

Who this might be right for
Kidney TransplantKidney/Pancreas Transplant
Providence Health & Services 60
Large-scale testing (Phase 3)Study completedNCT00045292
What this trial is testing

Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Not applicableEnded earlyNCT00957736
What this trial is testing

Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 252
Large-scale testing (Phase 3)Study completedNCT00239785
What this trial is testing

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 684
Large-scale testing (Phase 3)Study completedNCT02334488
What this trial is testing

Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function

Who this might be right for
Chronic Kidney Disease
Poitiers University Hospital 329
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Next Page